Abstract
Influenza A (H7N9) emerged earlier this year as a health threat in China. Efforts to develop a vaccine are under way. This letter presents initial phase 1 clinical data on the safety and immunogenicity of a candidate vaccine.
Cite
CITATION STYLE
APA
Fries, L. F., Smith, G. E., & Glenn, G. M. (2013). A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine. New England Journal of Medicine, 369(26), 2564–2566. https://doi.org/10.1056/nejmc1313186
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free